Patent · US Active

Adamantyl benzamide derivatives

US8927549B2 · kind B2 · utility

0Cited by

46References

63Claims

0Family size

Assignee

High Point Pharmaceuticals, LLC · US

Inventors

Dharma Rao Polisetti · High Point, US
Suparna Gupta · Greensboro, US
Soren Ebdrup · Roskilde, DK

Key dates

Filing date	Nov 17, 2009
Grant date	Jan 6, 2015
Priority date	—
Expiry date	Nov 17, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D239/42
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Embodiments of the present invention provide adamantyl benzamide derivatives and pharmaceutical compositions comprising adamantyl benzamide derivatives. Methods of use of such compounds and compositions to modulate the activity of 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) in a subject are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.